Is dasatinib a chemotherapy drug?

Dasatinib (Dasatinib) is an oral anti-cancer targeted therapy drug classified as a second-generation BCR-ABL tyrosine kinase inhibitor (TKI) used to treat certain types of blood or bone marrow cancers. It is used to treat Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (Ph+ CML) or all stages of acute lymphoblastic leukemia (Ph+ ALL) in adults and children. The Philadelphia chromosome is a defective stretch of DNA that promotes the development of leukemia cells. Leukemia is either acute (occurs quickly) or chronic (occurs over a long period of time). Dasatinib It works by blocking specific proteins on cancer cells that promote cancer growth. This can help shrink the cancer or stop it from growing.